HERON THERAPEUTICS, INC. /DE/
HRTX—
HERON THERAPEUTICS, INC. /DE/HRTX$0.00
+$0.00(+NaN%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
—
P/E ratio
—
EPS (diluted)
$-0.12
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$154.90M
Net income
$-20.20M
Net margin
-13.0%
Gross margin
73.3%
Dividends & financials
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported revenue of $154.90M and net income of $-20.20M, or $-0.12 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.